Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Strange

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
The Journal of Rheumatology|February 12, 2009
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in sclerodermaMargaret C Garin, Kristin B Highland, Richard M Silver, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 16, 2021
A Novel Detection Method to Identify Individuals with Alpha-1 Antitrypsin Deficiency: Linking Prescription of COPD Medications with the Patient-Facing Electronic Medical RecordSimon W Lam, Charlie Strange, Mark L Brantly, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2020
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency RegistryFranck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, et al.
Radiation Medicine|February 28, 2008
Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegalyJonathan I Osorio, John M Watkins, Charlie Strange, et al.
Cleveland Clinic Journal of Medicine|January 11, 2008
Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunitiesJames K Stoller, Leonard Fromer, Mark Brantly, et al.
Theranostics|July 9, 2019
Clathrin-mediated Endocytosis of Alpha-1 Antitrypsin is Essential for its Protective Function in Islet Cell SurvivalJingjing Wang, Wenyu Gou, Do-Sung Kim, et al.
COPD|May 5, 2015
The United States Alpha-1 Foundation Research Registry: Genesis, Impact and FutureCharlie Strange, Richard Monk, Laura Schwarz, et al.
Respiration; International Review of Thoracic Diseases|September 6, 2005
Results of a survey of patients with alpha-1 antitrypsin deficiencyCharlie Strange, James K Stoller, Robert A Sandhaus, et al.
Journal of Cellular and Molecular Medicine|October 29, 2024
Immortalized mesenchymal stromal cells overexpressing alpha-1 antitrypsin protect acinar cells from apoptotic and ferroptotic cell deathSara Shoeibi, Erica Green, Hua Wei, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 7, 2023
Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Patient Experiences With Self-Infusion, Home Providers, and ClinicsCharlie Strange, Sheri Allison, Jean McCathern, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
The Journal of Rheumatology|February 12, 2009
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in sclerodermaMargaret C Garin, Kristin B Highland, Richard M Silver, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 16, 2021
A Novel Detection Method to Identify Individuals with Alpha-1 Antitrypsin Deficiency: Linking Prescription of COPD Medications with the Patient-Facing Electronic Medical RecordSimon W Lam, Charlie Strange, Mark L Brantly, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2020
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency RegistryFranck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, et al.
Radiation Medicine|February 28, 2008
Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegalyJonathan I Osorio, John M Watkins, Charlie Strange, et al.
Cleveland Clinic Journal of Medicine|January 11, 2008
Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunitiesJames K Stoller, Leonard Fromer, Mark Brantly, et al.
Theranostics|July 9, 2019
Clathrin-mediated Endocytosis of Alpha-1 Antitrypsin is Essential for its Protective Function in Islet Cell SurvivalJingjing Wang, Wenyu Gou, Do-Sung Kim, et al.
COPD|May 5, 2015
The United States Alpha-1 Foundation Research Registry: Genesis, Impact and FutureCharlie Strange, Richard Monk, Laura Schwarz, et al.
Respiration; International Review of Thoracic Diseases|September 6, 2005
Results of a survey of patients with alpha-1 antitrypsin deficiencyCharlie Strange, James K Stoller, Robert A Sandhaus, et al.
Journal of Cellular and Molecular Medicine|October 29, 2024
Immortalized mesenchymal stromal cells overexpressing alpha-1 antitrypsin protect acinar cells from apoptotic and ferroptotic cell deathSara Shoeibi, Erica Green, Hua Wei, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 7, 2023
Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Patient Experiences With Self-Infusion, Home Providers, and ClinicsCharlie Strange, Sheri Allison, Jean McCathern, et al.
Pageof 20